NCT00097422View on ClinicalTrials.gov

OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 1, 2004

Primary Completion Date

April 1, 2005

Study Completion Date

April 1, 2005

Conditions
Diarrhea
Interventions
DRUG

OPT-80

Trial Locations (1)

18938

Advanced Biologics, New Hope

All Listed Sponsors
lead

Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

INDUSTRY

NCT00097422 - OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD) | Biotech Hunter | Biotech Hunter